Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*BDNF↑, *p‑Akt↑, *PI3K↑,
*cognitive↑, *p‑Akt↑, *p‑GSK‐3β↑, *p‑tau↓, *neuroP↑, *NF-kB↓, *AMPK↑, *NRF2↑,
*BDNF↑, *TrkB↑, *Akt↑, *CREB↑, *memory↑, *cognitive↑,
*BDNF↑, *TrkB↑, *PI3K↑, *Akt↑, *Apoptosis↓, *Inflam↓, *antiOx↑,
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
NA, |
NA, |
1- |
|
|
|
selectivity↑, ROS↑, Akt↑, FOXO3↓, Apoptosis↑,
*memory↑, *p‑Akt↑, *BACE↓, *cognitive↑,
*PI3K↑, *Akt↑, p‑Akt↓, SIRT3↑, p‑ERK↓, p38↓, VEGF↓, MEK↓, MKK4↓, MMP9↓, Raf↓, F-actin↓, MMP2↓, COX2↓, BMP2↓, cycD1/CCND1↓, Bax:Bcl2↑, EMT↓, EGFR↓, TumAuto↑,
*BDNF↑, *TrkB↓, *PI3K↑, *Akt↑, *neuroP↑,
| - |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
*creat↓, *TNF-α↓, *IL6↓, *MRP↓, *GFR↑, *mt-ATPase↑, *p‑Akt↑, *NRF2↑, *HO-1↑, *Casp3↓, *NF-kB↓, *RenoP↑,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1, SIRT3↑, 1,
Mitochondria & Bioenergetics ⓘ
MEK↓, 1, MKK4↓, 1, Raf↓, 1,
Cell Death ⓘ
Akt↑, 1, p‑Akt↓, 1, Apoptosis↑, 1, Bax:Bcl2↑, 1, BMP2↓, 1, p38↓, 1,
Autophagy & Lysosomes ⓘ
TumAuto↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, p‑ERK↓, 1, FOXO3↓, 1,
Migration ⓘ
F-actin↓, 1, MMP2↓, 1, MMP9↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1,
Drug Metabolism & Resistance ⓘ
selectivity↑, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1,
Total Targets: 24
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, HO-1↑, 1, NRF2↑, 2,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, CREB↑, 1,
Cell Death ⓘ
Akt↑, 4, p‑Akt↑, 4, Apoptosis↓, 1, Casp3↓, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑GSK‐3β↑, 1, PI3K↑, 4,
Migration ⓘ
mt-ATPase↑, 1,
Barriers & Transport ⓘ
MRP↓, 1,
Immune & Inflammatory Signaling ⓘ
IL6↓, 1, Inflam↓, 1, NF-kB↓, 2, TNF-α↓, 1,
Synaptic & Neurotransmission ⓘ
BDNF↑, 4, p‑tau↓, 1, TrkB↓, 1, TrkB↑, 2,
Protein Aggregation ⓘ
BACE↓, 1,
Clinical Biomarkers ⓘ
creat↓, 1, IL6↓, 1,
Functional Outcomes ⓘ
cognitive↑, 3, GFR↑, 1, memory↑, 2, neuroP↑, 2, RenoP↑, 1,
Total Targets: 29
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:4 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page